Targeting mitochondrial dysfunction to intervene in liver cancer

Area of Science:

• Hepatocellular carcinoma research
• Mitochondrial biology
• Cancer metabolism

Background:

• Mitochondrial dysfunction is a key driver in liver cancer occurrence and progression.
• Mitochondria regulate energy metabolism (Warburg effect) and apoptosis, influencing tumor proliferation and drug resistance.
• Mitochondrial DNA mutations and impaired mitophagy exacerbate liver cancer invasiveness and metastasis.

Purpose of the Study:

• To review the role of mitochondrial dysfunction in liver cancer.
• To discuss current therapeutic strategies targeting mitochondria.
• To highlight future directions for precision medicine in liver cancer treatment.

Main Methods:

• Literature review of studies on mitochondrial dysfunction in liver cancer.
• Analysis of current targeted therapeutic strategies.
• Discussion of challenges and future research directions.

Main Results:

• Mitochondrial dysfunction, including altered oxidative phosphorylation and reactive oxygen species accumulation, promotes liver cancer.
• mtDNA mutations and mitophagy dysregulation enhance cancer's invasive potential.
• Current therapies targeting mitochondrial pathways show promise but face challenges like heterogeneity and resistance.

Conclusions:

• Targeting mitochondrial dysfunction is a critical strategy for liver cancer therapy.
• Future research should focus on precision medicine, targeted delivery, combination therapies, and biomarkers.
• Advances in targeting mitochondria hold potential for significantly improving liver cancer patient prognosis.